Sugammadex
Sold as Bridion, Myladion, Sugammadex mylan, Desugomyl, Senuom, Damagus, Revergam, Selreding, Sugammadex DRL, Temadex, Neuvysi, Sumabid iv, Brevistell iv, Sugammadex iv austell, Sugammadex PD, Revoroc, Sugammadex sandoz, Bridade, Sugmasol, Amasug, Sugammadex fresenius, Sumazyd, Subrinex, Sugammadex equity, Diradex, Subraxx, Sugaflux, Revmadex, Sugammadex msd, Muscudex, Anedex, Neudexa
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 20
- Registrations
- 48
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Msd (Pty) Ltd | Bridion, Sugammadex msd | 100 mg/ml | 440432, 580139 | S4 | None |
| Viatris South Africa (Pty) LtdCertificate held by Mylan (Pty) Ltd | Myladion, Sugammadex mylan, Desugomyl | 100 mg | 550385, 550386.385, 550387.386 | S4 | PIPIL |
| Cipla Medpro (Pty) LtdCertificate held by Cipla medpro (pty)ltd | Senuom | 100 mg | 550542 | S4 | PIPIL |
| Lebasi Pharmaceuticals (Pty) Ltd | Damagus, Revergam, Selreding | 200 mg/2 ml, 500 mg/5 ml | 550585, 550586, 550587.585, 550588.586, 550589.585, 550590.586 | S4 | None |
| Dr Reddyæs Laboratories (Pty) Ltd | Sugammadex DRL, Neuvysi | 200, 500 | 550852, 550853, 560214, 560215 | S4 | None |
| Teva Pharmaceuticals (Pty) Ltd | Temadex | 200, 500 | 550899, 550900 | S4 | None |
| Ranbaxy Pharmaceutical (Pty) LtdCertificate held by Ranbaxy Pharmaceuticals (Pty) Ltd | Sumabid iv | 100 mg | 560244 | S4 | PIPIL |
| Austell Pharmaceuticals (Pty) Ltd | Brevistell iv, Sugammadex iv austell | Not stated | 560456, 560457.456 | S4 | None |
| Pharma Dynamics (Pty) Ltd | Sugammadex PD | Not stated | 560525 | S4 | None |
| Sandoz South Africa (Pty) Ltd | Revoroc, Sugammadex sandoz | 200 mg/2 ml, 500 mg/5 ml | 560555, 560556, 560557.555, 560558.556 | S4 | None |
| Juno Pharma SA (Pty) Ltd | Bridade | 200 mg, 500 mg | 560619, 560620 | S4 | None |
| Hetero Drugs South Africa (Pty) Ltd | Sugmasol, Amasug | 200 mg/2 ml, 500 mg/5 ml | 560660, 560661, 560662.660, 560663.661 | S4 | None |
| Fresenius Kabi South Africa (Pty) Ltd | Sugammadex fresenius | 100 mg/1ml, 200 mg/2ml, 500 mg/5ml | 560943, 560944, 560945 | S4 | None |
| Abex Pharmaceutica (Pty) Ltd | Sumazyd, Subrinex, Subraxx | 200 mg/2 mL, 200 mg/2 ml (100 mg/ml) | 561039, 561040.1039, 570239 | S4 | PIPIL |
| Equity Pharmaceutical (Pty) Ltd | Sugammadex equity | Not stated | 561193 | S4 | None |
| Encha Health (Pty) Ltd | Diradex | 200mg | 561211 | S4 | PIPIL |
| RBC Pharmaceuticals (Pty) Ltd | Sugaflux | 100 mg | 570572 | S4 | PIPIL |
| Accord Healthcare (Pty) Ltd | Revmadex | 200 mg/2ml, 500 mg/5 ml | 570658, 570659 | S4 | None |
| Adcock Ingram Critical Care (Pty) Ltd | Muscudex | 100 mg/ml | 590056 | S4 | PIPIL |
| Zydus Healthcare (Pty) Ltd | Anedex, Neudexa | 200 mg/2 ml, 500 mg/5 ml | 590298, 590299, 590300.298, 590301.299 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Bridion solution for injection 100 mg/ml EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 100,0 mg | 100 mg/mlSolution for injection | 44043244/34/0432 | Registered | S4 | None |
| Myladion 100 mg/ml Each 1,0 ml Solution contains: Sugammadex 100,0 mg | 100 mgSolution for injection | 55038555/34/0385Approved 22 November 2022 | Registered | S4 | PIPIL |
| Sugammadex 100 mg/ml mylan Each 1,0 ml solution contains: Sugammadex 100,0 mg | 100 mgSolution for injection | 550386.38555/34/0386.385Approved 22 November 2022 | Registered | S4 | PIPIL |
| Desugomyl 100 mg/ml Each 1,0 ml Solution contains: Sugammadex 100,0 mg | 100 mgSolution for injection | 550387.38655/34/0387.385Approved 22 November 2022 | Registered | S4 | PIPIL |
| Senuom 2 ML EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 100,0 mg | 100 mgSolution for injection | 55054255/34/0542Approved 24 January 2023 | Registered | S4 | PIPIL |
| Damagus 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2 ml | 55058555/2.11/0585 | Registered | S4 | None |
| Damagus 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5 ml | 55058655/2.11/0586 | Registered | S4 | None |
| Revergam 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2 ml | 550587.58555/2.11/0587.585 | Registered | S4 | None |
| Revergam 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5 ml | 550588.58655/2.11/0588.586 | Registered | S4 | None |
| Selreding 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2 ml | 550589.58555/2.11/0589.585 | Registered | S4 | None |
| Selreding 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5 ml | 550590.58655/2.11/0590.586 | Registered | S4 | None |
| Sugammadex 200 DRL EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 | 55085255/34/0852 | Registered | S4 | None |
| Sugammadex 500 DRL EACH 5,0 ml VIAL CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 | 55085355/34/0853 | Registered | S4 | None |
| Temadex 200 EACH 2,0 ml VIAL CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 | 55089955/34/0899 | Registered | S4 | None |
| Temadex 500 EACH 2,0 ml VIAL CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 | 55090055/34/0900 | Registered | S4 | None |
| Neuvysi 200 EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 | 56021456/34/0214 | Registered | S4 | None |
| Neuvysi 500 EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 | 56021556/34/0215 | Registered | S4 | None |
| Sumabid 100 iv EACH 1,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM 100,0 mg | 100 mgSolution for injection | 56024456/34/0244Approved 3 August 2022 | Registered | S4 | PIPIL |
| Brevistell iv EACH VIAL CONTAINS SUGAMMADEX SODIUMEQUIVALENT TO SUGAMMADEX 200,0 mg | Not listed | 56045656/34/0456 | Registered | S4 | None |
| Sugammadex iv austell EACH VIAL CONTAINS SUGAMMADEX SODIUMEQUIVALENT TO SUGAMMADEX 200,0 mg | Not listed | 560457.45656/34/0457.456 | Registered | S4 | None |
| Sugammadex PD EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | Not listed | 56052556/34/0525 | Registered | S4 | None |
| Revoroc 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2 ml | 56055556/32.16/0555 | Registered | S4 | None |
| Revoroc 500 mg/5 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5 ml | 56055656/32.16/0556 | Registered | S4 | None |
| Sugammadex 200 mg/2 ML sandoz EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2 ml | 560557.55556/32.16/0557.555 | Registered | S4 | None |
| Sugammadex 500 mg/5 ML sandoz EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5 ml | 560558.55656/32.16/0558.556 | Registered | S4 | None |
| Bridade 200 MG EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX OCTASODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | 200 mg | 56061956/34/0619 | Registered | S4 | None |
| Bridade 500 MG EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX OCTASODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | 500 mg | 56062056/34/0620 | Registered | S4 | None |
| Sugmasol 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 mg/2 ml | 56066056/34/0660 | Registered | S4 | None |
| Sugmasol 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 mg/5 ml | 56066156/34/0661 | Registered | S4 | None |
| Amasug 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 mg/2 ml | 560662.66056/34/0662.660 | Registered | S4 | None |
| Amasug 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 mg/5 ml | 560663.66156/34/0663.661 | Registered | S4 | None |
| Sugammadex 100 mg/1ml fresenius EACH VIAL CONTAINS SUGAMMADEX SODIUM 100,0 mg | 100 mg/1ml | 56094356/34/0943 | Registered | S4 | None |
| Sugammadex 200 mg/2ml fresenius EACH VIAL CONTAINS SUGAMMADEX SODIUM 200,0 mg | 200 mg/2ml | 56094456/34/0944 | Old Medicine | S4 | None |
| Sugammadex 500 mg/5ml fresenius EACH VIAL CONTAINS SUGAMMADEX SODIUM 500,0 mg | 500 mg/5ml | 56094556/34/0945 | Registered | S4 | None |
| Sumazyd EACH 1,0 ml SOLUTION CONTAINS :SUGAMMADEX 100,0 mg | 200 mg/2 mLSolution for injection | 56103956/32.16/1039Approved 19 March 2025 | Registered | S4 | PIPIL |
| Subrinex EACH 1,0 ml SOLUTION CONTAINS :SUGAMMADEX 100,0 mg | 200 mg/2 mLSolution for injection | 561040.103956/32.16/1040.1039Approved 18 June 2024 | Registered | S4 | PIPIL |
| Sugammadex equity EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX 200,0 mg | Not listed | 56119356/2.11/1193 | Registered | S4 | None |
| Diradex EACH 2,0 ml SOLUTION CONTAINS SUGAMMADEX 200,0 mg | 200mgSolution for injection | 56121156/2.11/1211Approved 25 March 2025 | Registered | S4 | PIPIL |
| Subraxx EACH 1,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | 200 mg/2 ml (100 mg/ml)Solution for injection | 57023957/32.16/0239Approved 20 August 2025 | Registered | S4 | PIPIL |
| Sugaflux EACH 1,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | 100 mgInjection | 57057257/17.3/0572Approved 28 July 2026 | Registered | S4 | PIPIL |
| Revmadex 200 mg/2ml each 2,0 ml solution contains: Sugammadex sodium equivalent to Sugammadex 200,0 mg | 200 mg/2ml | 57065857/34/0658 | Registered | S4 | None |
| Revmadex 500 mg/5 ML Each 5,0 ml solution contains: Sugammadex sodium equivalent to Sugammadex 500,0 mg | 500 mg/5 ml | 57065957/17.3/0659 | Registered | S4 | None |
| Sugammadex 100 mg/ml solution for injection msd EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX 100,0 mg | 100 mg/mlSolution for injection | 58013958/34/0139 | Registered | S4 | None |
| Muscudex 100 mg/ml EACH 1,0 ml SOLUTION CONTAINS SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 100,0 mg | 100 mg/mlSolution for injection | 59005659/34/0056Approved 10 September 2024 | Registered | S4 | PIPIL |
| Anedex 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 mg/2 ml | 59029859/2.11/0298 | Registered | S4 | None |
| Anedex 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO | 500 mg/5 ml | 59029959/2.11/0299 | Registered | S4 | None |
| Neudexa 200 mg/2 ML EACH 2,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 200,0 mg | 200 mg/2 ml | 590300.29859/2.11/0300.298 | Registered | S4 | None |
| Neudexa 500 mg/5 ML EACH 5,0 ml SOLUTION CONTAINS: SUGAMMADEX SODIUM EQUIVALENT TO SUGAMMADEX 500,0 mg | 500 mg/5 ml | 590301.29959/2.11/0301.299 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Sugammadex sodium
S4: Sugammadex
Consolidated Schedules 06 July 2026, line 7997
Pharmacological class: Complementary Medicines: Health Supplements (class 34)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Myladion 100 mg/ml, Viatris South Africa (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.